Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors

(2015) M. A. Dimopoulos et al.   ANNALS OF ONCOLOGY

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

(2015) E. Terpos et al.   HAEMATOLOGICA

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies

(2015) David C. Smith et al.   INVESTIGATIONAL NEW DRUGS

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

(2015) E. Terpos et al.   HAEMATOLOGICA

Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma

(2014) S. K. Kumar et al.   BLOOD

Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients

(2014) P. G. Richardson et al.   BLOOD

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

(2014) H. Ludwig et al.   HAEMATOLOGICA

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

(2014) Shaji K Kumar et al.   LANCET ONCOLOGY

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

(2014) M A Dimopoulos et al.   LEUKEMIA

Current treatments for renal failure due to multiple myeloma

(2013) Efstathios Kastritis et al.   EXPERT OPINION ON PHARMACOTHERAPY

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety

(2013) A Z Badros et al.   LEUKEMIA

Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers

(2012) Katharina Oehrlein et al.   Clinical Lymphoma Myeloma & Leukemia

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

(2012) M A Dimopoulos et al.   LEUKEMIA

Novel approaches for reducing free light chains in patients with myeloma kidney

(2012) Colin A. Hutchison et al.   Nature Reviews Nephrology

Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis

(2012) C. A. Hutchison et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

(2010) Meletios Dimopoulos et al.   CANCER

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

(2010) Javier De La Rubia et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

(2010) Heinz Ludwig et al.   JOURNAL OF CLINICAL ONCOLOGY

Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

(2010) Meletios A. Dimopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis

(2009) C. A. Hutchison et al.   Clinical Journal of the American Society of Nephrology

Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study

(2009) D. J. Tsakiris et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

(2008) J F San-Miguel et al.   LEUKEMIA

Pathogenesis and treatment of renal failure in multiple myeloma

(2008) M A Dimopoulos et al.   LEUKEMIA

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens

(2008) Maria Roussou et al.   LEUKEMIA & LYMPHOMA